[go: up one dir, main page]

WO2009141544A3 - Utilisation de wolfberry pour le traitement de la secheresse de la peau - Google Patents

Utilisation de wolfberry pour le traitement de la secheresse de la peau Download PDF

Info

Publication number
WO2009141544A3
WO2009141544A3 PCT/FR2009/050741 FR2009050741W WO2009141544A3 WO 2009141544 A3 WO2009141544 A3 WO 2009141544A3 FR 2009050741 W FR2009050741 W FR 2009050741W WO 2009141544 A3 WO2009141544 A3 WO 2009141544A3
Authority
WO
WIPO (PCT)
Prior art keywords
wolfberry
skin
treating dryness
wolfberries
strawberries
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/FR2009/050741
Other languages
English (en)
Other versions
WO2009141544A2 (fr
Inventor
Isabelle Castiel
Audrey Gueniche
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nestec SA
LOreal SA
Original Assignee
Nestec SA
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec SA, LOreal SA filed Critical Nestec SA
Publication of WO2009141544A2 publication Critical patent/WO2009141544A2/fr
Publication of WO2009141544A3 publication Critical patent/WO2009141544A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A61K36/815—Lycium (desert-thorn)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9728—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Botany (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medical Informatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

La présente invention concerne l'utilisation cosmétique d'une quantité efficace d'un extrait de baie choisie parmi le Wolfberry, la myrtille, la canneberge, la mûre, la groseille, la groseille blanche à grappes, le cassis, la groseille rouge à grappes, la framboise, l'argousier, la fraise et l'arbouse, et plus particulièrement de Wolfberry, comme agent pour prévenir et/ou traiter la sécheresse et/ou les désordres associés des matières kératiniques.
PCT/FR2009/050741 2008-04-21 2009-04-21 Utilisation d'un extrait de baie, et plus particulierement de wolfberry, pour le traitement de la secheresse des matieres keratiniques Ceased WO2009141544A2 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR0852679A FR2930153B1 (fr) 2008-04-21 2008-04-21 Utilisation d'un extrait de baie, et plus particulierement de wolfberry, pour le traitement de la secheresse des matieres keratiniques
FR0852679 2008-04-21
US5634008P 2008-05-27 2008-05-27
US61/056,340 2008-05-27

Publications (2)

Publication Number Publication Date
WO2009141544A2 WO2009141544A2 (fr) 2009-11-26
WO2009141544A3 true WO2009141544A3 (fr) 2010-04-22

Family

ID=39968048

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2009/050741 Ceased WO2009141544A2 (fr) 2008-04-21 2009-04-21 Utilisation d'un extrait de baie, et plus particulierement de wolfberry, pour le traitement de la secheresse des matieres keratiniques

Country Status (2)

Country Link
FR (1) FR2930153B1 (fr)
WO (1) WO2009141544A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106755185A (zh) * 2017-01-05 2017-05-31 青海康普生物科技股份有限公司 一种微生物法提取枸杞多糖产业化生产工艺

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102784259A (zh) * 2012-06-15 2012-11-21 沈士成 一种治疗红肿疔疮的外敷药物
CN105795280B (zh) * 2014-12-30 2019-07-09 广东智多星食品有限公司 一种枸杞提取物的提取方法及其应用
WO2017173241A1 (fr) 2016-03-31 2017-10-05 Gojo Industries, Inc. Composition de désinfectant comprenant un principe actif probiotique/prébiotique
EP3436156A1 (fr) 2016-03-31 2019-02-06 Gojo Industries, Inc. Composition nettoyante stimulant les peptides antimicrobiens
JP2020500860A (ja) 2016-11-23 2020-01-16 ゴジョ・インダストリーズ・インコーポレイテッド プロバイオティック／プレバイオティックな有効成分を含む消毒薬組成物
MX2020009313A (es) * 2018-03-08 2020-11-24 Plexus Worldwide Llc Composiciones y metodos para renovacion de la piel.
CA3206753A1 (fr) * 2021-02-01 2022-08-04 Roger Leger Procedes et compositions pour augmenter l'expression de proteines dans des bacteries genetiquement modifiees
CN112913999B (zh) * 2021-02-26 2023-09-19 安徽工程大学 一种枸杞红枣复合发酵式功能饮品及其制备方法
CN113855581A (zh) * 2021-08-11 2021-12-31 天津市康婷生物工程集团有限公司 一种多功能脂质体及其制备方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005079825A1 (fr) * 2004-02-19 2005-09-01 Kikkoman Corporation Remede oral pour la peau contenant de l'extrait de canneberge comme ingredient actif
WO2005092121A2 (fr) * 2004-03-19 2005-10-06 Nestec S.A. Apport d'ingredients fonctionnels
US20070166267A1 (en) * 2006-01-18 2007-07-19 Grant Industries, Inc. Anti-wrinkle composition
KR100753186B1 (ko) * 2006-09-07 2007-08-30 (주)더페이스샵코리아 생약추출 혼합물을 함유하는 피부 노화 방지용 화장료조성물

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005079825A1 (fr) * 2004-02-19 2005-09-01 Kikkoman Corporation Remede oral pour la peau contenant de l'extrait de canneberge comme ingredient actif
WO2005092121A2 (fr) * 2004-03-19 2005-10-06 Nestec S.A. Apport d'ingredients fonctionnels
US20070166267A1 (en) * 2006-01-18 2007-07-19 Grant Industries, Inc. Anti-wrinkle composition
KR100753186B1 (ko) * 2006-09-07 2007-08-30 (주)더페이스샵코리아 생약추출 혼합물을 함유하는 피부 노화 방지용 화장료조성물

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BENZIE I F F ET AL: "Enhanced bioavailabitlity of zeaxanthin in a milk-based formulation of wolfberry (Gou Qi Zi; Fructus barbarum L.)", BRITISH J. NUTRITION,, vol. 96, 1 January 2006 (2006-01-01), pages 154 - 160, XP009072766 *
LIANG J ET AL: "Influence of Lycium barbarum polysaccharide on activity of superoxide dismutase in rat skins", EMBASE HOST- EMBASE, 9 September 2007 (2007-09-09), XP002504582 *
ZHAO H ET AL: "Lycium barbarum glycoconjugates : effect on human skin and cultured dermal fibroblasts", PHYTOMEDICINE,, vol. 12, 1 January 2005 (2005-01-01), pages 131 - 137, XP004956914 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106755185A (zh) * 2017-01-05 2017-05-31 青海康普生物科技股份有限公司 一种微生物法提取枸杞多糖产业化生产工艺

Also Published As

Publication number Publication date
WO2009141544A2 (fr) 2009-11-26
FR2930153A1 (fr) 2009-10-23
FR2930153B1 (fr) 2012-05-04

Similar Documents

Publication Publication Date Title
WO2009141544A3 (fr) Utilisation de wolfberry pour le traitement de la secheresse de la peau
WO2009141542A3 (fr) Utilisation d'un extrait de baie, et plus particulierement de wolfberry, pour maintenir et/ou restaurer la tonicite et/ou la fermete de la peau
CL2008002089A1 (es) Compuesto para la regeneracion de tejidos que comprende al menos una sustancia derivada de sangre y acido hialuronico y/o al menos un compuesto derivado de acido hialuronico; metodo para la prepararcion de dicho compuesto.
EP2485736A4 (fr) Composés de dioxyde d'iminothiadiazine comme inhibiteurs de bace, compositions et leur utilisation
WO2008060622A3 (fr) Méthodes et compositions améliorées pour la cicatrisation des plaies
BRPI0918194A2 (pt) ''composto, composição farmacêutica, uso de um composto, método para tratar um indivíduo que sofre de uma condição patológica ou doença e produto de combinação
WO2014095289A3 (fr) Méthode de traitement du vieillissement capillaire
WO2009064767A3 (fr) Nanofibres bactéricides et procédés d'utilisation
BRPI0909768A2 (pt) composto, composição farmacêutica, método para o tratamento ou prevenção de uma doença ou distúrbio mediados pela ativação de b3-adrenoceptor, e, uso de um composto""composto, composição farmacêutica, método para o tratamento ou orevenção de uma doença ou distúrbio mediados pela ativação de b3-adrenoceptor, e, uso de um composto
BRPI0815079A2 (pt) Composto dericado de 1,2-diamido-etileno, composição farmacêutica que contém e uso desse composto
BR112013011109A2 (pt) ''organizador de fibras e caixa de distribuição''
ATE449771T1 (de) Azolylmethyloxirane, ihre verwendung zur bekämpfung von pflanzenpathogenen pilzen sowie sie enthaltende mittel
WO2010009892A8 (fr) Compositions destinées au traitement de la douleur et/ou de l'inflammation
BRPI0917705A2 (pt) composto, pró-droga, composição farmacêutica, método para tratar ou prevenir uma doença ou condição, e, uso do composto
EP2084139A4 (fr) Composés d'oxazolidinium et utilisation en tant qu'inhibiteurs d'hydrate
BRPI0516059A (pt) pelìcula proterora de piso, método para aplicar uma pelìcula ao piso, e, piso
BR112013013626A2 (pt) "composição cosmética, uso de uma composição cosmética e processo para tratar materiais queratínicos"
WO2009109457A3 (fr) Composition pour colorer des fibres de kératine comprenant au moins un colorant direct comprenant une fonction disulfure/thiol protégée et au moins un composé siliceux comprenant une fonction thiol et procédé utilisant la composition
BRPI0921522A2 (pt) composições para tratamento dos cabelos ou pêlos, métodos e artigos de comércio que podem melhorar a aparência de cabelos ou pêlos tornando-os mais espessos e mais cheios
ATE452131T1 (de) Azolylmethyloxirane, ihre verwendung zur bekämpfung von pflanzenpathogenen pilzen sowie sie enthaltende mittel
ATE495170T1 (de) Azolylmethyloxirane, ihre verwendung zur bekämpfung von pflanzenpathogenen pilzen sowie sie enthaltende mittel
CL2007002106A1 (es) COMPOSICION MONOFASICA LIQUIDA QUE COMPRENDE 3 ANTIOXIDANTES, 1o, COMPUESTO FENOLICO SINTETICO QUE NO ES DERIVADO DE QUINOOLINA, 2o, ACIDOS FENOLICO, ASCORBICO, TOCOFEROLES, LECITINA, BIOFLAVONOIDE O TERPENOIDE Y 3o, COMPUESTO DERIVADO DE QUINOLINA;
ATE496912T1 (de) Azolylmethyloxirane, ihre verwendung zur bekämpfung von pflanzenpathogenen pilzen sowie sie enthaltende mittel
BR112012028559A2 (pt) composições biocidas, e, uso de ésteres de oligoglicerol alcoxilados
WO2012136564A3 (fr) Composition cosmétique comprenant un composé acide cucurbique et un polymère semi-cristallin acrylique

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09750025

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09750025

Country of ref document: EP

Kind code of ref document: A2